Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Zydus Lifesciences Ltd.
NSE: ZYDUSLIFE
|
BSE: 532321
|
ISIN: INE010B01027
|
Industry: Pharmaceuticals
US FDA Approval
|
Mid-range Performer
968.9000
1.25
(
0.13
%)
NSE
Jul 16, 2025
15:52 PM
26.84% Fall from 52W High
Volume:
1.0M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Zydus Lifesciences Ltd.
13 Aug 2022
US FDA Approval
968.90
0.13%
Zydus Life Sciences
Hold:
Zydus Lifesciences Ltd.
by
ICICI Direct
Target: 405
ICICI Direct
Zydus Lifesciences L.. has an
average target
of 988.60 from 5 brokers.
More from Zydus Lifesciences Ltd.
Recommended
Market trades flat, Network18 Media & Investments' reports a net profit of Rs 148 crore in Q1
Trendlyne Marketwatch |
16 Jul 2025, 03:26PM
Five stocks to buy from analysts this week - July 15, 2025
The Baseline |
15 Jul 2025, 06:44PM
Earnings Call Transcript - Cadila Healthcare
|
14 Feb 2020